Temasek, Taikang lead $60m Series C2 round for Chinese speech therapy firm OST

Temasek, Taikang lead $60m Series C2 round for Chinese speech therapy firm OST

25 June, 2021

Orient Speech Therapy OST speech therapy taikang asset management Temasek Holdings

Printed by Unregistered user on Sat, 06 Dec 2025 10:31:38 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

[Updated] Temasek and Heliconia executives resign from ONE Championship's board

Temasek’s SeaTown seeks global opportunities for $1b private capital fund

Read more from Greater China

Alibaba to retire Ele.me brand amid instant-retail push

HongShan aims for $2.9b sale of Golden Goose to Permira by Christmas: report